Dr. Reddy's Laboratories Limited (RDY)

NYSE: RDY · Real-Time Price · USD

13.93

+0.53 (3.96%)

At close: May 12, 2025, 4:00 PM

13.94

+0.01 (0.07%)

After-hours: May 12, 2025, 7:59 PM EDT

Dr. Reddy's Laboratories Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Dr. Reddy's Laboratories stock has a target of 17, which predicts an increase of 22.04% from the current stock price of 13.93.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$17	$17	$17
Change	+22.04%	+22.04%	+22.04%	+22.04%

* Price targets were last updated on Nov 6, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Dr. Reddy's Laboratories is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Balaji Prasad Barclays	Barclays	Buy Maintains $17 → $17	Buy	Maintains	$17 → $17	+22.04%	Nov 6, 2024
Balaji Prasad Barclays	Barclays	Buy Maintains $16 → $17	Buy	Maintains	$16 → $17	+24.91%	Jul 30, 2024
Balaji Prasad Barclays	Barclays	Buy Maintains $16 → $16	Buy	Maintains	$16 → $16	+16.30%	May 8, 2024
Balaji Prasad Barclays	Barclays	Buy Maintains $15 → $16	Buy	Maintains	$15 → $16	+14.86%	Jan 29, 2024
Balaji Prasad Barclays	Barclays	Buy Maintains $13 → $14	Buy	Maintains	$13 → $14	+0.50%	Jun 1, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

359.32B

from 325.54B

10.38%

from 325.54B

Revenue Next Year

355.43B

from 359.32B

-1.08%

from 359.32B

EPS This Year

72.80

from 67.78

7.41%

from 67.78

EPS Next Year

58.36

from 72.80

-19.83%

from 72.80

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	189.72B	214.39B	245.88B	279.16B	325.54B	359.32B	355.43B	387.33B
Revenue Growth	8.66%	13.00%	14.69%	13.54%	16.61%	10.38%	-1.08%	8.98%
EPS	20.73	28.34	54.17	66.80	67.78	72.80	58.36	74.98
EPS Growth	-11.71%	36.70%	91.16%	23.32%	1.46%	7.41%	-19.83%	28.46%
Forward PE	-	-	-	-	-	16.25	20.28	15.78
No. Analysts	-	-	-	-	-	36	34	3

Financial currency is INR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	391.8B	394.9B	402.5B
Avg	359.3B	355.4B	387.3B
Low	309.2B	318.7B	368.6B

Revenue Growth

Revenue Growth	2026	2027	2028
High	20.3%	9.9%	13.2%
Avg	10.4%	-1.1%	9.0%
Low	-5.0%	-11.3%	3.7%

EPS Forecast

EPS	2026	2027	2028
High	93.45	86.28	77.18
Avg	72.80	58.36	74.98
Low	58.02	34.59	72.04

EPS Growth

EPS Growth	2026	2027	2028
High	37.9%	18.5%	32.2%
Avg	7.4%	-19.8%	28.5%
Low	-14.4%	-52.5%	23.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.